Ly-6G Antibody, anti-mouse, PerCP-Vio® 700 130-124-208 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
Ly-6G Antibody, anti-mouse, PerCP-Vio® 700

The Ly-6G Antibody, anti-mouse, PerCP-Vio® 700 from Miltenyi Biotec is a Rat Monoclonal antibody. This antibody recognizes Mouse antigen. The Ly-6G Antibody, anti-mouse, PerCP-Vio® 700 has been validated for the following applications: Flow Cytometry.

Product Specs
ItemLy-6G Antibody, anti-mouse, PerCP-Vio® 700
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-124-208
Antibody TypePrimary antibodies
Clonalitymonoclonal
Reactivitymouse
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
ApplicationsFlow cytometry
Clone1A8
IsotypeIgG2a
Quantity30 µg in 200 µL
Hostrat
Research AreaFor research use only
TargetLy-6G
Conjugate/TagPerCP-Vio 700
Concentration1:50
NCBI Full Gene Namelymphocyte antigen 6 complex, locus G
NCBI Gene AliasesGr, Gr-, Gr-1, Gr1, Ly-6, Ly-6G
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

Be the First to Write a Review!

Webinar: Improving Cancer Biomarker Detection with Multiplex Technology
The quantification of soluble biomarkers, including chemokines and cytokines, in plasma or serum is ... Read More
Screening of Leukemic Neoantigen Specific T cells with the iQue Screener PLUS
In this webinar, Alison Tarke, a Research Scientist at PersImmune, delivers the presentation "... Read More